iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA)
IDNA is a passive ETF by iShares tracking the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. IDNA launched on Jun 11, 2019 and has a 0.47% expense ratio.
ETF Info
| ISIN | US46435U1925 |
|---|---|
| CUSIP | 46435U192 |
| Issuer | iShares |
| Inception Date | Jun 11, 2019 |
| Region | North America (U.S.) |
| Category | Health & Biotech Equities |
| Index Tracked | NYSE FactSet Global Genomics and Immuno Biopharma Index |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
IDNA has a high expense ratio of 0.47%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund had a return of 3.69% year-to-date (YTD) and -0.87% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 3.69% | 7.50% |
| 1 month | 2.36% | -1.61% |
| 6 months | 23.53% | 17.65% |
| 1 year | -0.87% | 26.26% |
| 5 years (annualized) | N/A | 11.73% |
| 10 years (annualized) | N/A | 10.64% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3.13% | 8.61% | -0.54% | -6.19% | ||||||||
| 2023 | -10.96% | 13.85% | 12.37% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of IDNA is 16, indicating that it is in the bottom 16% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund(IDNA)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund granted a 1.01% dividend yield in the last twelve months. The annual payout for that period amounted to $0.24 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Dividend | $0.24 | $0.24 | $0.14 | $0.31 | $0.12 | $0.24 |
Dividend yield | 1.01% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 |
| 2019 | $0.24 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund was 68.26%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund drawdown is 56.08%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.26% | Sep 3, 2021 | 541 | Oct 27, 2023 | — | — | — |
| -26.93% | Mar 5, 2020 | 8 | Mar 16, 2020 | 23 | Apr 17, 2020 | 31 |
| -22.23% | Feb 9, 2021 | 19 | Mar 8, 2021 | 107 | Aug 9, 2021 | 126 |
| -14.38% | Jul 19, 2019 | 58 | Oct 9, 2019 | 30 | Nov 20, 2019 | 88 |
| -13.58% | Jul 21, 2020 | 35 | Sep 8, 2020 | 23 | Oct 9, 2020 | 58 |
Volatility
Volatility Chart
The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund volatility is 6.54%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.